243 related articles for article (PubMed ID: 7734306)
1. The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.
Lindmark G; Bergström R; Påhlman L; Glimelius B
Br J Cancer; 1995 May; 71(5):1090-4. PubMed ID: 7734306
[TBL] [Abstract][Full Text] [Related]
2. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman UH; Roberts PJ
Br J Cancer; 1996 Sep; 74(6):925-9. PubMed ID: 8826859
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
Carpelan-Holmström M; Haglund C; Lundin J; Järvinen H; Roberts P
Eur J Cancer; 1996 Jun; 32A(7):1156-61. PubMed ID: 8758246
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
5. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
[TBL] [Abstract][Full Text] [Related]
6. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Br J Cancer; 1994 Mar; 69(3):562-5. PubMed ID: 8123488
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
[TBL] [Abstract][Full Text] [Related]
9. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
10. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
[TBL] [Abstract][Full Text] [Related]
11. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
12. Preoperative carbohydrate antigen 195 (CA195) and CEA serum levels as prognostic factors in patients with colorectal cancer.
Andicoechea A; Vizoso F; Alexandre E; Cuesta E; Cruz Díez M; Miera L; García-Muñiz JL; Martínez E; Ruibal A
Int J Biol Markers; 1998; 13(3):158-64. PubMed ID: 10079391
[TBL] [Abstract][Full Text] [Related]
13. The tumour marker CA 195 in colorectal and pancreatic cancer.
Sagar PM; Taylor OM; Cooper EH; Benson EA; McMahon MJ; Finan PJ
Int J Biol Markers; 1991; 6(4):241-6. PubMed ID: 1795132
[TBL] [Abstract][Full Text] [Related]
14. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.
Eskelinen M; Pasanen P; Kulju A; Janatuinen E; Miettinen P; Poikolainen E; Tarvainen R; Nuutinen P; Pääkkönen M; Alhava E
Anticancer Res; 1994; 14(3B):1427-32. PubMed ID: 8067718
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum levels of CEA and CA 242 in colorectal cancer.
Carpelan-Holmström M; Haglund C; Kuusela P; Järvinen H; Roberts PJ
Br J Cancer; 1995 Apr; 71(4):868-72. PubMed ID: 7710956
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients.
Kim SB; Fernandes LC; Saad SS; Matos D
Int J Biol Markers; 2003; 18(3):182-7. PubMed ID: 14535588
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.
Duffy MJ; van Dalen A; Haglund C; Hansson L; Klapdor R; Lamerz R; Nilsson O; Sturgeon C; Topolcan O
Eur J Cancer; 2003 Apr; 39(6):718-27. PubMed ID: 12651195
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CEA and CA 19-9 in colorectal cancer in Kuwait.
Behbehani AI; Al-Sayer H; Farghaly M; Kanawati N; Mathew A; al-Bader A; Van Dalen A
Int J Biol Markers; 2000; 15(1):51-5. PubMed ID: 10763141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
